Siegfried Confirms the Forecast Despite a Restrained Half-Year
Summary by Moneycab
1 Articles
1 Articles
After a half-year of low growth, the pharmaceutical supplier Siegfried confirmed the forecasts for 2025. In the first semester, the Zofingers were still held back by the customer's and the strong Swiss francs.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium